XML 64 R44.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
Common Stock
Preferred stock
Series A Preferred stock
Preferred stock
Series B Preferred stock
Additional Paid-in Capital
Accumulated comprehensive loss
Accumulated deficit
Total
Beginning balance at Dec. 31, 2019 $ 90 $ 10,722,511     $ 138,954 $ (5,834,051) $ 5,027,504
Beginning balance (in shares) at Dec. 31, 2019 9,000,000 9,260,547          
Net loss           (4,630,168) (4,630,168) [1]
Conversion of convertible notes   $ 2,000,000         2,000,000
Conversion of convertible notes (in shares)   816,326          
Stock-based compensation expenses       $ (181,191)     (181,191)
Foreign currency translation adjustments         107,249   107,249 [1]
Ending balance at Dec. 31, 2020 $ 90 $ 12,722,511   181,191 246,203 (10,464,219) 2,685,776
Ending balance (in shares) at Dec. 31, 2020 9,000,000 10,076,873          
Net loss           (14,472,494) (14,472,494) [1]
Issuance of warrant       345,880     345,880
Issuance of common stock upon settlement of restricted stock units       767,908     767,908
Issuance of common stock upon settlement of restricted stock units (in shares) 3,411,057            
Conversion of convertible notes     $ 8,848,947       8,848,947
Conversion of convertible notes (in shares)     3,764,020        
Stock-based compensation expenses       (83,843)     (83,843)
Issuance of series B preferred Stock     $ 29,710,000       29,710,000
Issuance of Class B ordinary shares to Sponsor (in shares)     8,221,262        
Exercise of stock-based awards       17,005     17,005
Exercise of stock-based awards (in shares) 25,375            
Foreign currency translation adjustments         (7,467,497)   (7,467,497) [1]
Ending balance at Dec. 31, 2021 $ 90 $ 12,722,511 $ 38,558,947 1,395,827 (7,221,294) (24,936,713) 20,519,368
Ending balance (in shares) at Dec. 31, 2021 12,436,432 10,076,873 11,985,282        
Ending balance at Dec. 31, 2021 $ 90 $ 12,722,511 $ 38,558,947 1,395,827 (7,221,294) (24,936,713) 20,519,368
Ending balance (in shares) at Dec. 31, 2021 12,436,432 10,076,873 11,985,282        
Net loss           (6,633,074) (6,633,074)
Stock-based compensation expenses       783,996     783,996
Exercise of stock-based awards $ 250     1,376     1,376
Foreign currency translation adjustments         (336,705)   (336,705)
Ending balance at Jun. 30, 2022 $ 90 $ 12,722,511 $ 38,558,947 2,181,199 (7,557,999) (31,569,787) 14,334,961
Ending balance (in shares) at Jun. 30, 2022 12,436,682 10,076,873 11,985,282        
Beginning balance at Dec. 31, 2021 $ 90 $ 12,722,511 $ 38,558,947 1,395,827 (7,221,294) (24,936,713) 20,519,368
Beginning balance (in shares) at Dec. 31, 2021 12,436,432 10,076,873 11,985,282        
Net loss           (14,245,878) (14,245,878)
Stock-based compensation expenses       (1,657,709)     (1,657,709)
Exercise of stock-based awards       5,174     5,174
Exercise of stock-based awards (in shares) 15,625            
Foreign currency translation adjustments         (336,705)   (336,705)
Ending balance at Dec. 31, 2022 $ 90 $ 12,722,511 $ 38,558,947 3,058,710 (7,557,999) (39,182,591) 7,599,668
Ending balance (in shares) at Dec. 31, 2022 12,452,057 10,076,873 11,985,282        
Net loss           (12,000,418) (12,000,418)
Stock-based compensation expenses       573,545     573,545
Exercise of stock-based awards $ 70,000     8,125     8,125
Ending balance at Jun. 30, 2023 $ 90 $ 12,722,511 $ 38,558,947 $ 3,640,380 $ (7,557,999) $ (51,183,009) $ (3,819,080)
Ending balance (in shares) at Jun. 30, 2023 12,522,057 10,076,873 11,985,282        
[1] See restatement of financial statements in note 2.4 for further details.